NEW YORK, May 4 (GenomeWeb News) - HTG today said that Merck has licensed its ArrayPlate qNPA (quantitative nuclease protection assay) technology for its drug discovery research.

ArrayPlate qNPA offers multiplexed measurement of 16 mRNA species in each well of a standard 96-well microplate, HTG said.

HTG did not provide financial details of the licensing agreement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.